Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
Reader Response: Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
Keller, David L.
Neurology ; 99(13): 585, 2022 09 27.
Article in English | MEDLINE | ID: mdl-36163330

Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors , Intracranial Arteriosclerosis , Parkinsonian Disorders , Aged , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Intracranial Arteriosclerosis/complications , Parkinsonian Disorders/complications , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/epidemiology , Risk Factors
2.
Reader response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
Keller, David L.
Neurology ; 93(6): 279, 2019 08 06.
Article in English | MEDLINE | ID: mdl-31383807

Subject(s)
Parkinson Disease , Parkinsonian Disorders , Humans , Research Design
3.
To the Editor: Prostate cancer screening.
Keller, David L.
Cleve Clin J Med ; 85(12): 908, 2018 12.
Article in English | MEDLINE | ID: mdl-30526761

Subject(s)
Erectile Dysfunction , Prostatic Hyperplasia , Prostatic Neoplasms , Early Detection of Cancer , Humans , Male , Mass Screening , Men's Health , Prostate-Specific Antigen
4.
To the Editor: Obstructive sleep apnea.
Keller, David L.
Cleve Clin J Med ; 83(10): 703, 2016 10.
Article in English | MEDLINE | ID: mdl-27726832

Subject(s)
Sleep Apnea, Obstructive , Humans
5.
In Defense of Off-label Prescribing.
Keller, David L.
JAMA Intern Med ; 176(6): 861, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27273485

Subject(s)
Off-Label Use , Practice Patterns, Physicians' , Humans
6.
Patients Have a Right to All Their Medical Test Results.
Keller, David L.
Am J Med ; 129(10): e233-4, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27235008

Subject(s)
Colorectal Neoplasms/diagnosis , Disclosure/ethics , Disclosure/legislation & jurisprudence , Ethics, Medical , Feces/chemistry , Mass Screening/methods , Patient Rights , Early Detection of Cancer , Humans , United States , United States Food and Drug Administration
7.
To the Editor: Risk of falls.
Keller, David L.
Cleve Clin J Med ; 82(8): 473, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26270420

Subject(s)
Accidental Falls , Risk Assessment , Humans , Risk Factors
8.
To the Editor: The role of sentinel lymph node biopsy after excision of melanomas.
Keller, David L.
Cleve Clin J Med ; 82(8): 479, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26270422

Subject(s)
Melanoma , Sentinel Lymph Node Biopsy , Humans , Lymph Node Excision , Lymph Nodes , Lymphatic Metastasis , Skin Neoplasms
9.
Nonneurologists and the Dopamine Transporter Scan.
Keller, David L.
JAMA Intern Med ; 175(8): 1418, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26236969

Subject(s)
Essential Tremor/diagnosis , Physical Examination/standards , Humans , Male
10.
Corrections regarding prostate-specific antigen editorial.
Keller, David L.
JAMA Intern Med ; 175(6): 1067-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26030857

Subject(s)
Evidence-Based Medicine , Prostate-Specific Antigen/analysis , Prostatic Neoplasms/diagnosis , Humans , Male
11.
Coenzyme Q10 and statin-induced myopathy--I.
Keller, David L.
Mayo Clin Proc ; 90(3): 419-20, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25744125

Subject(s)
Creatine Kinase, MM Form/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Myalgia , Ubiquinone/analogs & derivatives , Humans
12.
Ethanol should be subjected to a randomized controlled trial.
Keller, David L.
Mayo Clin Proc ; 90(1): 160, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25572202

Subject(s)
Alcohol Drinking/adverse effects , Cardiovascular Diseases/mortality , Hypertension/mortality , Female , Humans , Male
13.
In defense of screening for breast cancer with magnetic resonance imaging.
Keller, David L.
JAMA Intern Med ; 174(8): 1417, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25090183

Subject(s)
Breast Neoplasms/diagnosis , Breast/pathology , Early Detection of Cancer/methods , Magnetic Resonance Imaging/statistics & numerical data , Female , Humans
14.
Adverse cardiac effects of bisphosphonates.
Keller, David L.
Mayo Clin Proc ; 89(7): 1025-6, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24996241

Subject(s)
Diphosphonates/adverse effects , Femoral Fractures/epidemiology , Myocardial Infarction/chemically induced , Myocardial Infarction/epidemiology , Osteoporosis/drug therapy , Osteoporosis/epidemiology , Spinal Fractures/epidemiology , Female , Humans , Male
15.
A comment on a CME test question (December 2013).
Keller, David L.
Cleve Clin J Med ; 81(6): 336, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24891531

Subject(s)
Angioedema/chemically induced , Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Contraindications , Humans
16.
Comments regarding "My thyroid story".
Keller, David L.
JAMA Intern Med ; 174(6): 1009, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24887768

Subject(s)
Thyroid Gland/surgery , Thyroid Neoplasms/surgery , Thyroidectomy , Humans
17.
Lowering blood glucose without increasing mortality.
Keller, David L.
Am J Med ; 127(5): e25, 2014 May.
Article in English | MEDLINE | ID: mdl-24758881

Subject(s)
Diabetes Complications/metabolism , Diabetes Complications/mortality , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/mortality , Glycated Hemoglobin/metabolism , Humans
18.
How government incentive payments affect readmissions.
Keller, David L.
BMJ ; 348: g1292, 2014 Feb 05.
Article in English | MEDLINE | ID: mdl-24500351

Subject(s)
Patient Readmission , Reimbursement, Incentive/organization & administration , Disclosure , Financing, Government/organization & administration , Humans , Patient Readmission/statistics & numerical data , Reimbursement, Incentive/statistics & numerical data
19.
Canagliflozin.
Keller, David L.
Cleve Clin J Med ; 81(2): 88-90, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24493489

Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Glucosides/therapeutic use , Thiophenes/therapeutic use , Humans
20.
Why I will continue to screen prostate-specific antigen for myself and other appropriate men.
Keller, David L.
JAMA Intern Med ; 174(1): 164, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24394929

Subject(s)
Biomarkers, Tumor/blood , Defensive Medicine , Direct Service Costs , Early Detection of Cancer , Informed Consent , Prescriptions , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Unnecessary Procedures , Humans , Male
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL